Prenetics’ IM8 Names Brian J. Rosin as Successor Chief Financial Officer

Danny Yeung, Co-Founder and Chief Executive Officer of Prenetics

“When Brian joined us in May, the plan was for him to learn IM8 from the inside and then lead finance for the whole company. He has done exactly that. Prenetics today is IM8, and one CFO with Brian’s background in high-growth consumer health is the right structure for where we are going. The United States is IM8’s largest market and our primary capital market, so that is where our finance leadership needs to sit: close to our customers, our investors and the analysts who cover us. With Brian and Cindy leading a U.S.-based finance team, we are building the reporting and controls infrastructure to match the scale we are growing into. I also want to thank Stephen for eight years of dedication and for his partnership through our transformation.”

Stephen Lo, Chief Financial Officer of Prenetics

“Being part of Prenetics’ journey over the past eight years, from our early days to the transformation into IM8, has been a privilege. I’m leaving at a time when the business has never had more momentum, and I’m certain that under Danny’s leadership IM8 will keep reaching new heights and bringing new innovations to customers around the world. I’ve worked closely with Brian since he joined, and I have full confidence in him to lead finance for the Company. I look forward to supporting a seamless transition through year-end, and to continuing to support the team as a Senior Advisor.”

Brian J. Rosin, Chief Financial Officer-designate of Prenetics

“Over the past six months I’ve had the chance to work inside IM8 every day, from our customer economics to the financing that funds our growth — and what we’re building is rare: a global brand compounding at this pace, this early in its life. Prenetics today is IM8. With Cindy and our finance leadership team now based in the United States, our largest market, my focus as CFO will be simple: disciplined capital allocation, a clear path to sustained profitability, and consistent, transparent communication with our shareholders. I’m grateful to Danny and the Board for their confidence, and to Stephen for his partnership through this transition.”